Invitrogen™ CTS™ CytoTune™-iPS 2.1 Sendai Reprogramming Kit

Description

• The CTS™ CytoTune™-iPS 2.1 Sendai Reprogramming Kit is the first off-the-shelf reprogramming system designed for clinical and translational research
• Like the CytoTune-iPS 2.0 Sendai reprogramming kit, this kit uses Sendai particles to deliver Yamanaka factors that are critical for efficient generation of induced pluripotent stem cells (iPSCs)
• This kit includes three vector preparations: polycistronic Klf4–Oct3/4–Sox2 (KOS), L-Myc, and Klf4
• Manufactured in accordance with GMP requirements: This product is manufactured at a site with an ISO9001-certified quality management system
• The facility and process were audited for conformity with current Good Manufacturing Practices for medical devices, 21 CFR Part 820 of the regulation
• Formulated animal origin–free: The bovine serum albumin carrier protein was removed from the CTS CytoTune-iPS 2.1 Sendai vector formulation
• The preparation contains no animal-derived components at the primary component level
• Accompanied by documentation to support your regulatory filing: Full traceability documentation such as Certificate of Origin and Certificate of Analysis are available
• What you get: The kit includes 0.2 mL of each vector (KOS, Klf4, and L-myc) at a titer of 0.5–2.0 x 10 8 CFU/mL, sufficient to reprogram a minimum of six wells of a six-well plate.